{"GPL16356": [{"GSM1049564": [{"title": "cervical tumour sample 14, batch2, affy_express, rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049565": [{"title": "cervical tumour sample 1, batch2, affy_express, rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049566": [{"title": "cervical tumour sample 18, batch2, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049567": [{"title": "cervical tumour sample 27, batch1, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049568": [{"title": "cervical tumour sample 38, batch1, affy_express, rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049569": [{"title": "normal cervix sample 3856, batch2, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal cervical epithelium"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: normal;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049570": [{"title": "normal cervix sample 3926, batch2, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal cervical epithelium"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: normal;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049571": [{"title": "cervical tumour sample 44, batch1, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049572": [{"title": "cervical tumour sample 45, batch2, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049573": [{"title": "cervical tumour sample 50, batch1, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049574": [{"title": "cervical tumour sample 57, batch1, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049575": [{"title": "cervical tumour sample 58, batch1, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049576": [{"title": "cervical tumour sample 67, batch2, affy_express, rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049577": [{"title": "cervical tumour sample 86, batch2, affy_express,rep1"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch2;\tprotocol: Affymetrix Express"}]}, {"GSM1049578": [{"title": "cervical tumour sample 14, batch3, nugen, rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049579": [{"title": "cervical tumour sample 1, batch3, nugen, rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049580": [{"title": "cervical tumour sample 18, batch3, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049581": [{"title": "cervical tumour sample 27, batch1, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049582": [{"title": "cervical tumour sample 38, batch1, nugen, rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049583": [{"title": "normal cervix sample 3856, batch1, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "normal cervical epithelium"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: normal;\tgender: Female;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049584": [{"title": "normal cervix sample 3926, batch3, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "normal cervical epithelium"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: normal;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049585": [{"title": "cervical tumour sample 44, batch1, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049586": [{"title": "cervical tumour sample 45, batch1, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049587": [{"title": "cervical tumour sample 50, batch1, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049588": [{"title": "cervical tumour sample 57, batch3, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049589": [{"title": "cervical tumour sample 58, batch3, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049590": [{"title": "cervical tumour sample 67, batch3, nugen, rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049591": [{"title": "cervical tumour sample 86, batch3, nugen,rep2"}, {"type": "RNA"}, {"source_name_ch1": "squamous cell carcinoma of the cervix"}, {"characteristics_ch1": "tissue: Cervix;\tdisease type: squamous cell carcinoma;\tgender: Female;\tbatch: Batch3;\tprotocol: Nugen"}]}, {"GSM1049592": [{"title": "kidney sample 1, batch 1, affy_express"}, {"type": "RNA"}, {"source_name_ch1": "normal kidney sample"}, {"characteristics_ch1": "tissue: Kidney;\tdisease type: normal;\tgender: N/A;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049593": [{"title": "kidney sample 2, batch 1, affy_express"}, {"type": "RNA"}, {"source_name_ch1": "normal kidney sample"}, {"characteristics_ch1": "tissue: Kidney;\tdisease type: normal;\tgender: N/A;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049594": [{"title": "RNA mixture control sample 1, batch 1, affy_express"}, {"type": "RNA"}, {"source_name_ch1": "RNA mixture control sample [Michigan reference RNA]"}, {"characteristics_ch1": "tissue: control;\tdisease type: normal;\tgender: N/A;\tbatch: Batch1;\tprotocol: Affymetrix Express"}]}, {"GSM1049595": [{"title": "kidney sample 1, batch 1, nugen"}, {"type": "RNA"}, {"source_name_ch1": "normal kidney sample"}, {"characteristics_ch1": "tissue: Kidney;\tdisease type: normal;\tgender: N/A;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049596": [{"title": "kidney sample 2, batch 1, nugen"}, {"type": "RNA"}, {"source_name_ch1": "normal kidney sample"}, {"characteristics_ch1": "tissue: Kidney;\tdisease type: normal;\tgender: N/A;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1049597": [{"title": "RNA mixture control sample 1, batch 1, nugen"}, {"type": "RNA"}, {"source_name_ch1": "RNA mixture control sample [Michigan reference RNA]"}, {"characteristics_ch1": "tissue: control;\tdisease type: normal;\tgender: N/A;\tbatch: Batch1;\tprotocol: Nugen"}]}, {"GSM1079898": [{"title": "A549-1 week-0-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to zero dose of sodium arsenite for 1 week replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: zero dose of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079899": [{"title": "A549-1 week-0-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to zero dose of sodium arsenite for 1 week replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: zero dose of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079900": [{"title": "A549-1 week-0.08-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.08 \u00b5M of sodium arsenite for 1 week replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.08 \u00b5M of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079901": [{"title": "A549-1 week-0.08-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.08 \u00b5M of sodium arsenite for 1 week replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.08 \u00b5M of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079902": [{"title": "A549-1 week-0.4-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.4 \u00b5M of sodium arsenite for 1 week replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.4 \u00b5M of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079903": [{"title": "A549-1 week-0.4-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.4 \u00b5M of sodium arsenite for 1 week replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.4 \u00b5M of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079904": [{"title": "A549-1 week-2-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 2 \u00b5M of sodium arsenite for 1 week replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 2 \u00b5M of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079905": [{"title": "A549-1 week-2-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 2 \u00b5M of sodium arsenite for 1 week replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 2 \u00b5M of sodium arsenite;\ttime: 1 week"}]}, {"GSM1079906": [{"title": "A549-2 weeks-0-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to zero dose of sodium arsenite for 2 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: zero dose of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079907": [{"title": "A549-2 weeks-0-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to zero dose of sodium arsenite for 2 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: zero dose of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079908": [{"title": "A549-2 weeks-0.08-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.08 \u00b5M of sodium arsenite for 2 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.08 \u00b5M of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079909": [{"title": "A549-2 weeks-0.08-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.08 \u00b5M of sodium arsenite for 2 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.08 \u00b5M of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079910": [{"title": "A549-2 weeks-0.4-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.4 \u00b5M of sodium arsenite for 2 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.4 \u00b5M of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079911": [{"title": "A549-2 weeks-0.4-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.4 \u00b5M of sodium arsenite for 2 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.4 \u00b5M of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079912": [{"title": "A549-2 weeks-2-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 2 \u00b5M of sodium arsenite for 2 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 2 \u00b5M of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079913": [{"title": "A549-2 weeks-2-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 2 \u00b5M of sodium arsenite for 2 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 2 \u00b5M of sodium arsenite;\ttime: 2 weeks"}]}, {"GSM1079914": [{"title": "A549-8 weeks-0-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to zero dose of sodium arsenite for 8 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: zero dose of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1079915": [{"title": "A549-8 weeks-0-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to zero dose of sodium arsenite for 8 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: zero dose of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1079916": [{"title": "A549-8 weeks-0.08-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.08 \u00b5M of sodium arsenite for 8 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.08 \u00b5M of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1079917": [{"title": "A549-8 weeks-0.08-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.08 \u00b5M of sodium arsenite for 8 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.08 \u00b5M of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1079918": [{"title": "A549-8 weeks-0.4-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.4 \u00b5M of sodium arsenite for 8 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.4 \u00b5M of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1079919": [{"title": "A549-8 weeks-0.4-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 0.4 \u00b5M of sodium arsenite for 8 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 0.4 \u00b5M of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1079920": [{"title": "A549-8 weeks-2-rep 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 2 \u00b5M of sodium arsenite for 8 weeks replicate 1"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 2 \u00b5M of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1079921": [{"title": "A549-8 weeks-2-rep 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from A549 cells exposed to 2 \u00b5M of sodium arsenite for 8 weeks replicate 2"}, {"characteristics_ch1": "cell type: A549 human epithelial lung carcinoma cells;\ttreatment: 2 \u00b5M of sodium arsenite;\ttime: 8 weeks"}]}, {"GSM1143935": [{"title": "OC-BAP- (negative) cells, sample Avo1 15.3, biological rep. 1"}, {"type": "RNA"}, {"source_name_ch1": "sorted OC-BAP- (negative) cells, from buffy coat"}, {"characteristics_ch1": "donor: 15.3;\tdonor phenotype: healthy, non diabetic;\ttissue: blood;\tcell type: OC-BAP- (negative) cells"}]}, {"GSM1143936": [{"title": "OC+BAP+ (positive) cells, sample Avo2 15.3, biological rep. 1"}, {"type": "RNA"}, {"source_name_ch1": "sorted OC+BAP+ (positive) cells, from buffy coat"}, {"characteristics_ch1": "donor: 15.3;\tdonor phenotype: healthy, non diabetic;\ttissue: blood;\tcell type: OC+BAP+ (positive) cells"}]}, {"GSM1143937": [{"title": "OC-BAP- (negative) cells, sample Avo3 20.3, biological rep. 2"}, {"type": "RNA"}, {"source_name_ch1": "sorted OC-BAP- (negative) cells, from buffy coat"}, {"characteristics_ch1": "donor: 20.3;\tdonor phenotype: healthy, non diabetic;\ttissue: blood;\tcell type: OC-BAP- (negative) cells"}]}, {"GSM1143938": [{"title": "OC+BAP+ (positive) cells, sample Avo4 20.3 biological rep. 2"}, {"type": "RNA"}, {"source_name_ch1": "sorted OC+BAP+ (positive) cells, from buffy coat"}, {"characteristics_ch1": "donor: 20.3;\tdonor phenotype: healthy, non diabetic;\ttissue: blood;\tcell type: OC+BAP+ (positive) cells"}]}, {"GSM1143939": [{"title": "OC-BAP- (negative) cells, sample Avo6 06.03, biological rep. 3"}, {"type": "RNA"}, {"source_name_ch1": "sorted OC-BAP- (negative) cells, from buffy coat"}, {"characteristics_ch1": "donor: 6.03;\tdonor phenotype: healthy, non diabetic;\ttissue: blood;\tcell type: OC-BAP- (negative) cells"}]}, {"GSM1143940": [{"title": "OC+BAP+ (positive) cells, sample Avo5 06.03, biological rep. 3"}, {"type": "RNA"}, {"source_name_ch1": "sorted OC+BAP+ (positive) cells, from buffy coat"}, {"characteristics_ch1": "donor: 6.03;\tdonor phenotype: healthy, non diabetic;\ttissue: blood;\tcell type: OC+BAP+ (positive) cells"}]}, {"GSM1255658": [{"title": "HepG2_10000_\u00b5M_Acetominophen_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_10000_\u00b5M_Acetominophen_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: APAP, 10000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255659": [{"title": "HepG2_10000_\u00b5M_Acetominophen_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_10000_\u00b5M_Acetominophen_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: APAP, 10000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255660": [{"title": "HepG2_10000_\u00b5M_Acetominophen_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_10000_\u00b5M_Acetominophen_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: APAP, 10000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255661": [{"title": "HepG2_50_\u00b5M_Adefovir_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_50_\u00b5M_Adefovir_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: ADF, 50 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255662": [{"title": "HepG2_50_\u00b5M_Adefovir_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_50_\u00b5M_Adefovir_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: ADF, 50 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255663": [{"title": "HepG2_50_\u00b5M_Adefovir_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_50_\u00b5M_Adefovir_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: ADF, 50 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255664": [{"title": "HepG2_15_\u00b5M_Amiodarone_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_15_\u00b5M_Amiodarone_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Amio, 15 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255665": [{"title": "HepG2_15_\u00b5M_Amiodarone_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_15_\u00b5M_Amiodarone_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Amio, 15 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255666": [{"title": "HepG2_15_\u00b5M_Amiodarone_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_15_\u00b5M_Amiodarone_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Amio, 15 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255667": [{"title": "HepG2_20_\u00b5M_Chlorpromazine_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_Chlorpromazine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CLP, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255668": [{"title": "HepG2_20_\u00b5M_Chlorpromazine_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_Chlorpromazine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CLP, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255669": [{"title": "HepG2_20_\u00b5M_Chlorpromazine_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_Chlorpromazine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CLP, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255670": [{"title": "HepG2_20_\u00b5M_CyclosporinA_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_CyclosporinA_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CsA, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255671": [{"title": "HepG2_20_\u00b5M_CyclosporinA_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_CyclosporinA_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CsA, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255672": [{"title": "HepG2_20_\u00b5M_CyclosporinA_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_CyclosporinA_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CsA, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255673": [{"title": "HepG2_550_\u00b5M_Diclofenac_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_550_\u00b5M_Diclofenac_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DIC, 550 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255674": [{"title": "HepG2_550_\u00b5M_Diclofenac_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_550_\u00b5M_Diclofenac_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DIC, 550 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255675": [{"title": "HepG2_550_\u00b5M_Diclofenac_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_550_\u00b5M_Diclofenac_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DIC, 550 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255676": [{"title": "HepG2_2000_\u00b5M_D-mannitol_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_D-mannitol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: MAN, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255677": [{"title": "HepG2_2000_\u00b5M_D-mannitol_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_D-mannitol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: MAN, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255678": [{"title": "HepG2_2000_\u00b5M_D-mannitol_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_D-mannitol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: MAN, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255679": [{"title": "HepG2_0.5_%_DMSO_1_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_1_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255680": [{"title": "HepG2_0.5_%_DMSO_2_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_2_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255681": [{"title": "HepG2_0.5_%_DMSO_1_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_1_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255682": [{"title": "HepG2_0.5_%_DMSO_2_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_2_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255683": [{"title": "HepG2_0.5_%_DMSO_1_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_1_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255684": [{"title": "HepG2_0.5_%_DMSO_2_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_2_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255685": [{"title": "HepG2_0.5_%_DMSO_3_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_3_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255686": [{"title": "HepG2_0.5_%_DMSO_3_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_3_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255687": [{"title": "HepG2_0.5_%_DMSO_3_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_3_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255688": [{"title": "HepG2_90_\u00b5M_Ethinyl_estradiol_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_90_\u00b5M_Ethinyl_estradiol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Et, 90 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255689": [{"title": "HepG2_90_\u00b5M_Ethinyl_estradiol_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_90_\u00b5M_Ethinyl_estradiol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Et, 90 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255690": [{"title": "HepG2_90_\u00b5M_Ethinyl_estradiol_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_90_\u00b5M_Ethinyl_estradiol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Et, 90 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255691": [{"title": "HepG2_2000_\u00b5M_Isoniazid_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Isoniazid_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: ISO, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255692": [{"title": "HepG2_2000_\u00b5M_Isoniazid_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Isoniazid_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: ISO, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255693": [{"title": "HepG2_2000_\u00b5M_Isoniazid_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Isoniazid_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: ISO, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255694": [{"title": "HepG2_2000_\u00b5M_Lithium_Carbonate_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Lithium_Carbonate_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: LiC, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255695": [{"title": "HepG2_2000_\u00b5M_Lithium_Carbonate_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Lithium_Carbonate_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: LiC, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255696": [{"title": "HepG2_2000_\u00b5M_Lithium_Carbonate_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Lithium_Carbonate_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: LiC, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255697": [{"title": "HepG2_120_\u00b5M_Paraquat_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_120_\u00b5M_Paraquat_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PAQ, 120 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255698": [{"title": "HepG2_120_\u00b5M_Paraquat_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_120_\u00b5M_Paraquat_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PAQ, 120 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255699": [{"title": "HepG2_120_\u00b5M_Paraquat_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_120_\u00b5M_Paraquat_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PAQ, 120 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255700": [{"title": "HepG2_0.5_%_PBS_1_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_1_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255701": [{"title": "HepG2_0.5_%_PBS_2_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_2_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255702": [{"title": "HepG2_0.5_%_PBS_1_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_1_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255703": [{"title": "HepG2_0.5_%_PBS_2_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_2_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255704": [{"title": "HepG2_0.5_%_PBS_1_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_1_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255705": [{"title": "HepG2_0.5_%_PBS_2_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_2_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255706": [{"title": "HepG2_2000_\u00b5M_Tetracycline_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Tetracycline_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: TET, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255707": [{"title": "HepG2_2000_\u00b5M_Tetracycline_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Tetracycline_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: TET, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255708": [{"title": "HepG2_2000_\u00b5M_Tetracycline_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Tetracycline_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: TET, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255709": [{"title": "HepG2_2000_\u00b5M_Valproic_Acid_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Valproic_Acid_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: VPA, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255710": [{"title": "HepG2_2000_\u00b5M_Valproic_Acid_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Valproic_Acid_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: VPA, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255711": [{"title": "HepG2_2000_\u00b5M_Valproic_Acid_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Valproic_Acid_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: VPA, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255712": [{"title": "HepG2_2000_\u00b5M_Cyclophosphamide_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Cyclophosphamide_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CP, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255713": [{"title": "HepG2_2000_\u00b5M_Cyclophosphamide_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Cyclophosphamide_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CP, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255714": [{"title": "HepG2_2000_\u00b5M_Cyclophosphamide_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Cyclophosphamide_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CP, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255715": [{"title": "HepG2_3_\u00b5M_CyclosporinA_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_3_\u00b5M_CyclosporinA_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CsA, 3 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255716": [{"title": "HepG2_3_\u00b5M_CyclosporinA_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_3_\u00b5M_CyclosporinA_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CsA, 3 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255717": [{"title": "HepG2_3_\u00b5M_CyclosporinA_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_3_\u00b5M_CyclosporinA_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CsA, 3 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255718": [{"title": "HepG2_30_\u00b5M_17-beta_Estradiol_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_30_\u00b5M_17-beta_Estradiol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: E2, 30 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255719": [{"title": "HepG2_30_\u00b5M_17-beta_Estradiol_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_30_\u00b5M_17-beta_Estradiol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: E2, 30 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255720": [{"title": "HepG2_30_\u00b5M_17-beta_Estradiol_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_30_\u00b5M_17-beta_Estradiol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: E2, 30 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255721": [{"title": "HepG2_0.5_%_DMSO_4_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_4_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255722": [{"title": "HepG2_0.5_%_DMSO_4_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_4_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255723": [{"title": "HepG2_0.5_%_DMSO_4_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_4_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255724": [{"title": "HepG2_1000_\u00b5M_Phenobarbital_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_1000_\u00b5M_Phenobarbital_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PhB, 1000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255725": [{"title": "HepG2_1000_\u00b5M_Phenobarbital_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_1000_\u00b5M_Phenobarbital_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PhB, 1000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255726": [{"title": "HepG2_1000_\u00b5M_Phenobarbital_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_1000_\u00b5M_Phenobarbital_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PhB, 1000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255727": [{"title": "HepG2_0.5_%_DMSO_5_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_5_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255728": [{"title": "HepG2_0.5_%_DMSO_5_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_5_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255729": [{"title": "HepG2_0.5_%_DMSO_5_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_5_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255730": [{"title": "HepG2_0.5_%_PBS_3_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_3_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255731": [{"title": "HepG2_0.5_%_PBS_3_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_3_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255732": [{"title": "HepG2_0.5_%_PBS_3_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_3_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255733": [{"title": "HepG2_250_\u00b5M_Azathioprine_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_250_\u00b5M_Azathioprine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: AZA, 250 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255734": [{"title": "HepG2_250_\u00b5M_Azathioprine_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_250_\u00b5M_Azathioprine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: AZA, 250 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255735": [{"title": "HepG2_250_\u00b5M_Azathioprine_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_250_\u00b5M_Azathioprine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: AZA, 250 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255736": [{"title": "HepG2_0.5_%_DMSO_6_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_6_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255737": [{"title": "HepG2_0.5_%_DMSO_6_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_6_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255738": [{"title": "HepG2_0.5_%_DMSO_6_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_6_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255739": [{"title": "HepG2_0.5_%_PBS_4_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_4_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255740": [{"title": "HepG2_0.5_%_PBS_4_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_4_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255741": [{"title": "HepG2_0.5_%_PBS_4_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_PBS_4_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: PBS, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255742": [{"title": "HepG2_0.2_\u00b5M_MitomycinC_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.2_\u00b5M_MitomycinC_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: MMC, 0.2 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255743": [{"title": "HepG2_0.2_\u00b5M_MitomycinC_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.2_\u00b5M_MitomycinC_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: MMC, 0.2 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255744": [{"title": "HepG2_0.2_\u00b5M_MitomycinC_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.2_\u00b5M_MitomycinC_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: MMC, 0.2 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255745": [{"title": "HepG2_250_\u00b5M_D-mannitol_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_250_\u00b5M_D-mannitol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Dman, 250 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255746": [{"title": "HepG2_250_\u00b5M_D-mannitol_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_250_\u00b5M_D-mannitol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Dman, 250 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255747": [{"title": "HepG2_250_\u00b5M_D-mannitol_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_250_\u00b5M_D-mannitol_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: Dman, 250 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255748": [{"title": "HepG2_20_\u00b5M_Cisplatin_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_Cisplatin_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: cisPt, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255749": [{"title": "HepG2_20_\u00b5M_Cisplatin_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_Cisplatin_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: cisPt, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255750": [{"title": "HepG2_20_\u00b5M_Cisplatin_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_20_\u00b5M_Cisplatin_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: cisPt, 20 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255751": [{"title": "HepG2_500_\u00b5M_Clonidine_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_500_\u00b5M_Clonidine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CLO, 500 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255752": [{"title": "HepG2_500_\u00b5M_Clonidine_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_500_\u00b5M_Clonidine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CLO, 500 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255753": [{"title": "HepG2_500_\u00b5M_Clonidine_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_500_\u00b5M_Clonidine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: CLO, 500 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255754": [{"title": "HepG2_106.25_\u00b5M_Nifedipine_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_106.25_\u00b5M_Nifedipine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: NFE, 106.25 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255755": [{"title": "HepG2_106.25_\u00b5M_Nifedipine_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_106.25_\u00b5M_Nifedipine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: NFE, 106.25 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255756": [{"title": "HepG2_106.25_\u00b5M_Nifedipine_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_106.25_\u00b5M_Nifedipine_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: NFE, 106.25 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255757": [{"title": "HepG2_2000_\u00b5M_Tolbutamide_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Tolbutamide_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: TOL, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255758": [{"title": "HepG2_2000_\u00b5M_Tolbutamide_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Tolbutamide_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: TOL, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255759": [{"title": "HepG2_2000_\u00b5M_Tolbutamide_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_2000_\u00b5M_Tolbutamide_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: TOL, 2000 \u00b5M;\ttreatment time: 24h"}]}, {"GSM1255760": [{"title": "HepG2_0.5_%_DMSO_7_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_7_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255761": [{"title": "HepG2_0.5_%_DMSO_7_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_7_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1255762": [{"title": "HepG2_0.5_%_DMSO_7_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2_0.5_%_DMSO_7_24h"}, {"characteristics_ch1": "cell line: HepG2;\tcell type: hepatocellular carcinoma;\tcompound, dose: DMSO, 0.5 %;\ttreatment time: 24h"}]}, {"GSM1219747": [{"title": "Glomerular compartment from E0 LN human kidney (Toronto Glomerulonephritis Registry Biobank) H_IgA_7"}, {"type": "RNA"}, {"source_name_ch1": "Kidney biopsy from human LN"}, {"characteristics_ch1": "tissue: Glomeruli from kidney biopsy;\tphenotype: endocapillary proliferation E0"}]}, {"GSM1219748": [{"title": "Glomerular compartment from E0 LN human kidney (Toronto Glomerulonephritis Registry Biobank) H_IgA_9"}, {"type": "RNA"}, {"source_name_ch1": "Kidney biopsy from human LN"}, {"characteristics_ch1": "tissue: Glomeruli from kidney biopsy;\tphenotype: endocapillary proliferation E0"}]}, {"GSM1219749": [{"title": "Glomerular compartment from E1 LN human kidney (Toronto Glomerulonephritis Registry Biobank) H_IgA_12"}, {"type": "RNA"}, {"source_name_ch1": "Kidney biopsy from human LN"}, {"characteristics_ch1": "tissue: Glomeruli from kidney biopsy;\tphenotype: endocapillary proliferation E1"}]}, {"GSM1219750": [{"title": "Glomerular compartment from E0 LN human kidney (Toronto Glomerulonephritis Registry Biobank) H_IgA_13"}, {"type": "RNA"}, {"source_name_ch1": "Kidney biopsy from human LN"}, {"characteristics_ch1": "tissue: Glomeruli from kidney biopsy;\tphenotype: endocapillary proliferation E0"}]}, {"GSM1219751": [{"title": "Glomerular compartment from E1 LN human kidney (Toronto Glomerulonephritis Registry Biobank) H_IgA_18"}, {"type": "RNA"}, {"source_name_ch1": "Kidney biopsy from human LN"}, {"characteristics_ch1": "tissue: Glomeruli from kidney biopsy;\tphenotype: endocapillary proliferation E1"}]}, {"GSM1219752": [{"title": "Glomerular compartment from E0 LN human kidney (Toronto Glomerulonephritis Registry Biobank) H_IgA_21"}, {"type": "RNA"}, {"source_name_ch1": "Kidney biopsy from human LN"}, {"characteristics_ch1": "tissue: Glomeruli from kidney biopsy;\tphenotype: endocapillary proliferation E0"}]}, {"GSM2046305": [{"title": "DFSP"}, {"type": "RNA"}, {"source_name_ch1": "Fresh dermatofibrosarcoma tumor"}, {"characteristics_ch1": "tissue: dermatofibrosarcoma"}]}, {"GSM2032000": [{"title": "Scrambled siRNA 1, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Glioma cells"}, {"characteristics_ch1": "cell line: U87MG;\ttransfection: scrambled siRNA"}]}, {"GSM2032001": [{"title": "Scrambled siRNA 1, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Glioma cells"}, {"characteristics_ch1": "cell line: U87MG;\ttransfection: scrambled siRNA"}]}, {"GSM2032002": [{"title": "Scrambled siRNA 1, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Glioma cells"}, {"characteristics_ch1": "cell line: U87MG;\ttransfection: scrambled siRNA"}]}, {"GSM2032003": [{"title": "ASCL1 siRNA 1, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Glioma cells"}, {"characteristics_ch1": "cell line: U87MG;\ttransfection: siRNA targeted against ASCL1"}]}, {"GSM2032004": [{"title": "ASCL1 siRNA 2, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Glioma cells"}, {"characteristics_ch1": "cell line: U87MG;\ttransfection: siRNA targeted against ASCL1"}]}, {"GSM2032005": [{"title": "ASCL1 siRNA 3, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Glioma cells"}, {"characteristics_ch1": "cell line: U87MG;\ttransfection: siRNA targeted against ASCL1"}]}, {"GSM2227769": [{"title": "Primary human hepatocyte 5 days control replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 1% ethanol for 5 days daily"}]}, {"GSM2227770": [{"title": "Primary human hepatocyte 5 days control replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 1% ethanol for 5 days daily"}]}, {"GSM2227771": [{"title": "Primary human hepatocyte 5 days control replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 1% ethanol for 5 days daily"}]}, {"GSM2227772": [{"title": "Primary human hepatocyte 5 days 15 mM valproic acid replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 15 mM valproic acid for 5 days daily"}]}, {"GSM2227773": [{"title": "Primary human hepatocyte 5 days 15 mM valproic acid replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 15 mM valproic acid for 5 days daily"}]}, {"GSM2227774": [{"title": "Primary human hepatocyte 5 days 15 mM valproic acid replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 15 mM valproic acid for 5 days daily"}]}, {"GSM2227775": [{"title": "Primary human hepatocyte 8 days control replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 1% ethanol for 5 days daily and subsequently to 3 days medium"}]}, {"GSM2227776": [{"title": "Primary human hepatocyte 8 days control replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 1% ethanol for 5 days daily and subsequently to 3 days medium"}]}, {"GSM2227777": [{"title": "Primary human hepatocyte 8 days control replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 1% ethanol for 5 days daily and subsequently to 3 days medium"}]}, {"GSM2227778": [{"title": "Primary human hepatocyte 5 days 15 mM valproic acid and 3 days medium replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 15 mM valproic acid for 5 days daily and subsequently to 3 days medium"}]}, {"GSM2227779": [{"title": "Primary human hepatocyte 5 days 15 mM valproic acid and 3 days medium replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 15 mM valproic acid for 5 days daily and subsequently to 3 days medium"}]}, {"GSM2227780": [{"title": "Primary human hepatocyte 5 days 15 mM valproic acid and 3 days medium replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RNA from human primary hepatocytes"}, {"characteristics_ch1": "cell type: Primary human hepatocytes;\ttreatment: exposed to 15 mM valproic acid for 5 days daily and subsequently to 3 days medium"}]}]}